Haemonetics
About: Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Employees: 3,657
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
123% more call options, than puts
Call options by funds: $47.1M | Put options by funds: $21.1M
50% more funds holding in top 10
Funds holding in top 10: 2 [Q2] → 3 (+1) [Q3]
4% less capital invested
Capital invested by funds: $4.67B [Q2] → $4.46B (-$208M) [Q3]
7% less repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 112
2.24% less ownership
Funds ownership: 110.74% [Q2] → 108.5% (-2.24%) [Q3]
4% less funds holding
Funds holding: 316 [Q2] → 302 (-14) [Q3]
18% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 55
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
Needham Mike Matson 56% 1-year accuracy 69 / 123 met price target | 77%upside $108 | Buy Maintained | 7 Feb 2025 |
Barrington Research Michael Petusky 52% 1-year accuracy 37 / 71 met price target | 56%upside $95 | Outperform Maintained | 7 Feb 2025 |
JP Morgan Rohin Patel 0% 1-year accuracy 0 / 1 met price target | 91%upside $116 | Overweight Initiated | 6 Dec 2024 |
Raymond James Andrew Cooper 23% 1-year accuracy 3 / 13 met price target | 97%upside $120 | Strong Buy Upgraded | 8 Nov 2024 |
Financial journalist opinion
Based on 10 articles about HAE published over the past 30 days









